Sandra Peterson leaves Bayer to join J&J as worldwide chair
This article was originally published in Scrip
Johnson & Johnson has appointed Sandra Peterson, currently chair and CEO of Bayer CropScience, group worldwide chair and a member of the executive committee effective 1 December 2012. Ms Peterson has been at Bayer CropScience since 2010, and was previously president and CEO of Bayer Medical Care and president of Bayer HealthCare’s diabetes division.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.